Oncology
The Department of Oncology and Hematology is a newly established key specialty at Suzhou BenQ Hospital. It mainly treats various solid malignant tumors, hematologic malignancies, and benign blood disorders.
Official department pageSource checked
Would you like help contacting the hospital?
Even if you already have the hospital’s contact details, a real person can help you organise your questions, contact the hospital and coordinate communication one to one.
The service includes one AI medical travel plan and one 1-to-1 consultation with a real person.
After purchasing, contact your adviser through your account.
Patient acceptance, appointments and fees are subject to confirmation by the hospital.
Doctors
Doctor profiles: 4
何志洁
Clinical interests
Comprehensive treatment, chemotherapy, immunotherapy, molecular targeted therapy, endocrine therapy, and cancer pain treatment for various malignant tumors; extensive clinical experience in cancer prevention and early screening.
杨光
Clinical interests
Read more
Proficient in comprehensive cancer treatment, chemotherapy, endocrine therapy, and biological therapy for malignant tumors; proficient in treating malignant pleural effusion, ascites, and pericardial effusion; specializes in CIK cell plus DC therapy for tumors; specializes in the diagnosis and treatment of difficult oncological diseases.
沈丽琴
Clinical interests
Read more
Long-term clinical work in oncology, with proficiency in diagnosing and treating various solid tumors and good clinical experience managing difficult and complicated tumor cases. Has conducted research on the latest cancer immunotherapies and has expertise in basic theoretical oncology research.
蔡伟波
Clinical interests
Read more
Forty years of clinical experience and theoretical knowledge; skilled in comprehensive diagnosis and treatment of solid tumors and hematologic diseases, including lung, gastrointestinal, breast, ovarian and prostate cancers, anemia, white-cell and platelet disorders, and lymphatic diseases. Proficient in chemotherapy, endocrine therapy, molecular targeted therapy and immunotherapy.